Cholesterol embolization treated with corticosteroids--two case reports

Jun-ichiro Koga1, Masahiko Ohno, Kazuhiko Okamoto

  • 1Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

Angiology
|August 5, 2005
PubMed

Insights

Cholesterol embolization (CE) is a serious complication of arterial procedures. Corticosteroid therapy, specifically oral prednisolone, showed promise in improving renal function in two patients with CE.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Pathology

Background:

  • Cholesterol embolization (CE) is a recognized complication following invasive arterial procedures.
  • Currently, no established standard therapy exists for managing CE.
  • Patients with severe atherosclerosis are at increased risk.

Observation:

  • Two cases of CE were observed in patients with severe atherosclerosis.
  • Renal function significantly deteriorated within months post-arterial procedures.
  • CE was histologically confirmed via renal biopsy in one case and skin biopsy in another.

Findings:

  • Oral administration of prednisolone (30 mg daily) was initiated.
  • A notable improvement in renal function was observed in both patients following corticosteroid treatment.
  • This suggests a potential therapeutic benefit of corticosteroids in CE management.

Implications:

  • Corticosteroid therapy may be a viable treatment option for select patients experiencing CE.
  • Further research is warranted to establish the efficacy and optimal use of corticosteroids in CE.
  • This finding could lead to improved patient outcomes and management strategies for this complication.

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: